|
【参考文献】
1 Fong DS, Aiello L, Gardner TW, et al. American diabetes association: diabetic retinopathy (Review). Diabetes Care2003;26(1):226229
2 Dagher Z, Park YS, Asnaghi V, et al. Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy.
Diabetes2004;53(9):24042411
3 Treins C, Giorgettiperaloli S, Murdaca J, et al. Regulation of vascular endothelial growth factor expression by advanced glycation end products. Biol Chem2001;276(47):43836 43841
4 Xu GX, Xu JB, Hu JZ. Expression of hypoxiainducible factor1α and vascular endothelial growth factor in the retina of diabetic rats. Int J Ophthalmol(Guoji Yanke Zazhi)2008;8(3):487 490
5 Moore TC, Moore JE, Kaji Y, et al. The role of advanced glycation end products in retinal microvascular leukostasis. Invest Ophthalmol Vis Sci 2003;44(10):4457 4464
6 Reber F, Geffarch R, Kasper M, et al. Graded sensitiveness of the various retinal neuron populations on the glyoxalmediated fomation of advance glycosylation end products and ways of protection. Graefes Arch Clin Exp Ophthalmol2003;241(3):213225
7 Greene DA, Arezzo JC, Brown MB. Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. zenarestat study group. Neurology1999;53(4):580591
8 Ola MS, Berkich DA， Xu Y，et al. Analysis of glucose metabolism in diabetic rat retinas. Am J Physiol Endocrinol Metab2006;290(6):E10571067
9 Lu BY, Wu ZF. Progress of research on pathogenesis of diabetic retinopathy. Int J Ophthalmol (Guoji Yanke Zazhi) 2008;8(11):23082311
10 Lorenzi M, Gerhardinger C. Early cellular and molecular changes induced by diabetes in the retina. Diabetologia2001;44(7):791804
11 Mylari BL, Armento SJ, Beebe DA, et al. A novel series of noncarboxylic acid, nonhydantoin inhibitors of aldose reductase with potent oral activity in diabetic rat models: 6(5chloro3methylbenzofuran2sulfonyl)2Hpyridazin3one and congeners. J Med Chem2005;48(20):6326 6339
12 Grant MB, Afzal A, Spoerri P, et al. The role of growth factors in the pathogenesis of diabetic retinopathy. Expert Opin Investig Drugs2004;13(10):12751293
13 Witmer AN, Vrensen GF, Van Noorden CJ, et al. Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 2003;22（1）:129
14 Obrosova IG, Minchenko AG, Vasupuram R, et al. Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocindiabetic rats. Diabetes 2003;52(3):864871
15 Bril V, Buchanan RA. Aldose reductase inhibition by AS3201 in sural nerve from patients with diabetic sensorimotor polyneuropathy. Diabetes
Care2004;27(10):23692375
16 Bril V, Buchanan RA. Longterm effects of ranirestat (AS3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy. Diabetes Care2006;29（1）:6872
17 Graesser D, Solowiej A, Bruckner M, et al. Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM1deficient mice. Clin Invest2002;109(3):383392
18 Asnaghi V, Gerhardinger C, Hoehn T, et al. A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes2003;52(2):506511
19 Engerman RL, Kern TS, Larson ME. Nerve conduction and aldose reductase inhibition during 5 years of diabetes or galactosaemia in dogs.
Diabetologia1994;37(2):141144
20 Dagher Z, Park YS, Asnaghi V, et al. Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy.
Diabetes2004;53(9):24042411
21 Sun W, Gerhardinger C, Dagher Z, et al. Aspirin at lowintermediate concentrations protects retinal vessels in experimental diabetic retinopathy through nonplateletmediated effects. Diabetes2005;54(12):34183426
22 Sun W, Oates PJ, Coutcher JB, et al. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy. Diabetes2006;55(10):27572762
23 Beltramo E, Berrone E, Buttiglieri S, et al. Thiamine and benfotiamine prevent increased apoptosis in endothelial cells and pericytes cultured in high glucose. Diabetes Metab Res Rev2004;20(4):330336
24 Hammes HP, Du X, Edelstein D, et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med2003;9(3):294299
上一页 [1] [2] |
